)

OnKure Therapeutics (OKUR) investor relations material
OnKure Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Completed merger with Reneo Pharmaceuticals, resulting in a reverse recapitalization and $65M concurrent financing; now trades on Nasdaq as OKUR.
Focused on advancing lead candidate OKI-219, a selective PI3Kα inhibitor, in Phase 1a/1b clinical trials for advanced breast cancer.
Completed enrollment in single agent and fulvestrant combination arms of PIKture-01 trial for OKI-219; data expected Q4 2025.
Initiated new expansion arms to evaluate OKI-219 in triplet combinations for HR+ and HER2+ metastatic breast cancer.
No product revenue to date; operations funded primarily through equity and convertible debt.
Financial highlights
Cash and cash equivalents totaled $83.4M as of June 30, 2025, providing runway into Q4 2026.
R&D expenses were $12.6M for Q2 2025, up from $10.8M in Q2 2024, mainly due to increased clinical and manufacturing costs.
G&A expenses were $3.7M for Q2 2025, slightly higher than $3.6M in Q2 2024, driven by personnel and professional fees.
Net loss for Q2 2025 was $15.4M ($1.14 per share), compared to $14.1M in Q2 2024.
Cash used in operating activities was $27.3M for the six months ended June 30, 2025.
Outlook and guidance
Expects R&D and G&A expenses to increase in 2025 as clinical programs advance and public company operations continue.
Data from PIKture-01 monotherapy and fulvestrant combination arms expected in Q4 2025.
Nomination of a pan-mutant selective PI3Ka inhibitor development candidate planned by end of 2025.
Cash runway projected into Q4 2026 based on current cash position.
Additional capital will be required to complete product development and commercialization; may seek equity, debt, or partnership funding.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage